Research Progress on Molecular Biomarkers Detection and Targeted Therapy for Ovarian Cancer
Abstract：More than 50,000 new cases of ovarian cancer are diagnosed in China each year, and approximately 30,000 women die from ovarian cancer annually. Ovarian cancer has become a malignant tumor that seriously affects the health of Chinese women [1]. The risk of recurrence and death in ovarian cancer is related to the stage at diagnosis, with higher risks for later stages. In recent years, with the development of precision medicine, identifying gene mutations in ovarian cancer through gene sequencing methods has become a key approach for guiding personalized targeted therapy for different patients.
Keywords：precision medicineovarian cancertargeted therapy
Publication Date：2025-04-02
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 474-477 )